Search

Author/Creator Ping, Jerry

1. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Issue 10 (5th April 2018)

Authors:
Ellingson, Benjamin M; Aftab, Dana T; Schwab, Gisela M; Hessel, Colin; Harris, Robert J; Woodworth, Davis C; Leu, Kevin; Chakhoyan, Ararat; Raymond, Catalina; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; ...
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 10(2018)
Page Start:
1411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study. Issue 1 (1st January 2022)

Authors:
Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Veronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Stev...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 1(2022)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy. Issue 2 (14th August 2017)

Authors:
Wen, Patrick Y; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; Holland, Jaymes; Ping, Jerry; Weitzman, Ron; Cloughesy, Timothy F
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)
Page Start:
249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Issue 2 (3rd October 2017)

Authors:
Cloughesy, Timothy F; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; Ping, Jerry; Holland, Jaymes; Weitzman, Ron; Wen, Patrick Y
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*. Issue 9 (29th July 2021)

Authors:
Wilson, Wyndham H.; Phillips, Tycel; Popplewell, Leslie; de Vos, Sven; Chhabra, Saurabh; Kimball, Amy S.; Beaupre, Darrin; Huang, Da Wei; Wright, George; Kwei, Kevin; Ping, Jerry; Neuenburg, Jutta K.; Staudt, Louis M.
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 9(2021)
Page Start:
2094
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma. (16th March 2020)

Authors:
Fowler, Nathan H.; Nastoupil, Loretta; De Vos, Sven; Knapp, Mark; Flinn, Ian W.; Chen, Robert; Advani, Ranjana H.; Bhatia, Sumeet; Martin, Peter; Mena, Raul; Davis, Richard Eric; Neelapu, Sattva S.; Eckert, Karl; Ping, Jerry; Co, Melannie; Beaupre, Darrin M.; Neuenburg, Jutta K.; Palomba, M. Lia
Journal:
British journal of haematology
Issue:
Volume 189:Number 4(2020)
Page Start:
650
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 study. (February 2023)

Authors:
Ramchandren, Radhakrishnan; Johnson, Peter; Ghosh, Nilanjan; Ruan, Jia; Ardeshna, Kirit M.; Johnson, Roderick; Verhoef, Gregor; Cunningham, David; de Vos, Sven; Kassam, Shireen; Fayad, Luis; Radford, John; Bailly, Sarah; Offner, Fritz; Morgan, David; Munoz, Javier; Ping, Jerry; Szafer-Glusman, Ed...
Journal:
EClinicalMedicine
Issue:
Volume 56(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗